Detection of antisense and ribozyme accessible sites on native mRNAs: Application to NCOA3 mRNA

Molecular Therapy

Volumn 4, Issue 5, 2001, Pages 454-460

  Scherr, Michaela ^a,b   LeBon, Jeanne ^a   Castanotto, Daniela ^a   Cunliffe, Heather E ^c   Meltzer, Paul S ^c   Ganser, Arnold ^a   Riggs, Arthur D ^a   Rossi, John J ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

Antisense; Breast cancer; NCOA3 mRNA; Ovarian cancer; Ribozyme; RNA structure; RNaseH

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; CELL EXTRACT; CELL NUCLEUS RECEPTOR; DNA NUCLEOTIDYLEXOTRANSFERASE; MESSENGER RNA; RIBONUCLEASE H; RIBOZYME;

ARTICLE; BASE PAIRING; BREAST CANCER; CELL FUNCTION; CONTROLLED STUDY; DNA LIBRARY; DNA RNA HYBRIDIZATION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC CODE; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; OVARY CANCER; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA CLEAVAGE; RNA STRUCTURE;

EID: 0035190643     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1006/mthe.2001.0481     Document Type: Article

References (26)

1. Ribozymes
2. Specific hammerhead ribozyme-mediated cleavage of mutant N-ras mRNA in vitro and ex vivo. Oligoribonucleotides as therapeutic agents
3. Nuclease-resistant ribozymes decrease stromelysin mRNA levels in rabbit synovium following exogenous delivery to the knee joint
4. The use of ribozymes to inhibit HIV replication
5. A synthetic, chemically modified ribozyme eliminates amelogenin, the major translation product in developing mouse enamel in vivo
6. Ribozymes, genomics and therapeutics
7. Optimal computer folding of large RNA sequences using thermodynamics and auxiliary information
8. Probing accessible sites for ribozymes on human acetylcholinesterase RNA
9. Mapping of RNA accessible sites for antisense experiments with oligonucleotide libraries
10. Selection of efficient ribozyme cleavage sites in target RNAs
11. A rapid in vitro method for obtaining RNA accessibility patterns for complementary DNA probes: Correlation with an intracellular pattern and known RNA structures
12. Prediction of antisense oligonucleotide efficacy by in vitro methods
13. Construction of a directed hammerhead ribozyme library: Towards the identification of optimal target sites for antisense-mediated gene inhibition
14. Rapid determination and quantitation of the accessibility to native RNAs by antisense oligodeoxynucleotides in murine cell extracts
15. Oligonucleotide scanning of native mRNAs in extracts predicts intracellular ribozyme efficiency: Ribozyme-mediated reduction of the murine DNA methyltransferase
16. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer
17. In vivo, high-resolution analysis of yeast and mammalian RNA-protein interactions, RNA structure, RNA splicing and ribozyme cleavage by use of terminal transferase-dependent PCR
18. Terminal transferase-dependent PCR: A versatile and sensitive method for in vivo footprinting and detection of DNA adducts
19. Protection of a T-cell line from human immunodeficiency virus replication by the stable expression of a short antisense RNA sequence carried by a shuttle RNA molecule
20. Downregulation of the CCR5 β-chemokine receptor and inhibition of HIV-1 infection by stable VA1-ribozyme chimeric transcripts
21. Steroid receptor coactivator-1 and its family members differentially regulate transactivation by the tumor suppressor protein p53
22. Ribozyme-targeting demonstrates that the nuclear receptor coactivator AIB1 is a rate limiting factor for estrogen-dependent growth of human MCF-7 breast cancer cells
23. A general purpose RNA-cleaving DNA enzyme
24. Ligation-mediated PCR for quantitative in vivo footprinting
25. Advanced mammalian gene transfer: High titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line
26. Faithful transcription of eukaryotic genes by RNA polymerase III in systems reconstituted with purified DNA templates